hsa-mir-762: Hsa-mir-762 is a microRNA that has been studied in various contexts [PMC6294505]. It has been found to be associated with genetic variants at the SYNGR1 locus, which is linked to rheumatoid arthritis risk [PMC6294505]. In the context of lung cancer, hsa-mir-762 has been identified as a potential biomarker [PMC7202328]. Future studies should focus on quantifying the expression levels of hsa-mir-762 in lung lesion biopsy samples from patients with disease progression after cisplatin chemotherapy [PMC7202328]. In another study, hsa-mir-762 was found to be under-expressed in certain microRNA profiles associated with cancer [PMC3440352]. Additionally, hsa-mir-762 has been predicted to interact with several other microRNAs, suggesting its potential role in regulatory networks [PMC7171488]. It has also been associated with pathogen infection [PMC5994059]. Furthermore, hsa-mir-762 was identified as one of the top miRNAs and was found to target several genes in a study on hepatopathy-related diseases [PMC5002491]. In patients with severe acute pancreatitis (SAP), hsa-mir-762 was significantly up-regulated compared to healthy controls and may be involved in the pathogenesis of acute lung injury (ALI) [PMC5685850]. Finally, hsa-mir-762 is one of the miRNAs selected as putative candidate targets for further studies based on their significance and implications in biological pathways [PMC4223555].